CALR and cancer: The targeted nanoclusters, anti-CRT-AuNCs, were previously shown to bind to HT29 and MCF7 cancer cells lines, grown in 2D monolayer cultures, demonstrating the potential of calreticulin as a cancer biomarker [16, 27].